Skip to content

The survey of girls precocious puberty in Shenzhen and the cohort study of relationship between Phthalate esters (PAEs) and evolve of precocious puberty

The survey of girls precocious puberty in Shenzhen and the cohort study of relationship between Phthalate esters and evolve of precocious puberty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020492
Enrollment
Unknown
Registered
2019-01-02
Start date
2019-01-14
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

precocious puberty

Interventions

Case series:no

Sponsors

Shenzhen Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
3 Years to 7.9 Years

Inclusion criteria

Inclusion criteria: IPT group inclusion criteria: 1. Girl appearing breast development before the age of 8, without signs of other sexual development, no nipple, areola pigmentation, no growth acceleration, no pubic hair / mane growth; 2. The size of the uterus and ovary is proportional to the actual age; 3. The GnRH stimulation test did not meet the Hypothalamic-pituitary-gonadal axis(HPGA) start; 4. The GnRH stimulation test confirmed the IPT girls to arrange a special follow-up weekend clinic, once every 3 months, can be completed with follow-up, that is, at least 1 year or 8 years old or diagnosed as ICPP.

Exclusion criteria

Exclusion criteria: IPT group rejection criteria: 1. CPP caused by organic lesions and peripheral precocious puberty; 2. Except for the recent accidental misuse of estrogens or the use of hormonal drugs or supplements/Chinese herbal medicines (including any of the following: royal jelly, bird's nest, Huajiao, ginseng, angelica, antler, placenta, cordyceps, hippocampus); 3. The family history of sexual precocity or a family history cannot be provided; 4. Abnormal physical birth (including births smaller than gestational age, giant children) or those who cannot provide birth history; 5. BMI exceeds the 85th percentile of the same sex with the same age. 6. The subject or parent rejects the examintion; 7. During the follow-up period, those who found organic lesions, not be able to review to the clinic on time and they will not cooperate with the urine specimens.

Design outcomes

Primary

MeasureTime frame
Mono-2-ethylhexyl phthalate, MEHP;Mono(2-ethyl-5-hyduoxyhexyl)phthalate, MEHHP;Mono(2-ethyl-5oxohexyl)phthalate, MEOHP;Mono (2-ethyl-5-carboxypentyl) phthalate, MECPP;(Mono [(2-carboxymethyl)hexyl] phthalate, MCMHP;Mono-n-butyl phthalate, MBP;Monobenzyl phthalate,MBzP;Monoisopropyl Phthalate, MiPrP;Monoisobutyl phthalat e, MiBP;Mono-ethyl phthalate, MEP;mono-n-pentyl?phthalate, MnPeP;Urinary creatinine;

Countries

China

Contacts

Public ContactSu Zhe

Shenzhen Children's Hospital

su_zhe@126.com+86 18926488907

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026